Dynamic Technology Lab Private Ltd Invests $549,000 in Phreesia, Inc. (NYSE:PHR)

Dynamic Technology Lab Private Ltd bought a new position in Phreesia, Inc. (NYSE:PHR) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 24,079 shares of the company’s stock, valued at approximately $549,000.

Other large investors have also made changes to their positions in the company. Deerfield Management Company L.P. Series C purchased a new position in Phreesia in the second quarter valued at about $4,078,000. Champlain Investment Partners LLC increased its position in shares of Phreesia by 4.1% in the 3rd quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock worth $57,062,000 after purchasing an additional 97,847 shares during the last quarter. Sei Investments Co. grew its stake in Phreesia by 135.3% in the second quarter. Sei Investments Co. now owns 165,327 shares of the company’s stock worth $3,505,000 after purchasing an additional 95,058 shares in the last quarter. Squarepoint Ops LLC grew its stake in Phreesia by 56.3% in the second quarter. Squarepoint Ops LLC now owns 250,396 shares of the company’s stock worth $5,308,000 after purchasing an additional 90,215 shares in the last quarter. Finally, SG Americas Securities LLC acquired a new position in Phreesia in the third quarter worth about $954,000. 92.10% of the stock is owned by hedge funds and other institutional investors.

Phreesia Stock Up 3.6 %

Phreesia stock opened at $21.03 on Friday. The firm has a market cap of $1.21 billion, a price-to-earnings ratio of -11.68 and a beta of 0.94. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.77 and a quick ratio of 1.77. Phreesia, Inc. has a fifty-two week low of $14.55 and a fifty-two week high of $29.16. The firm has a fifty day moving average price of $20.43 and a two-hundred day moving average price of $21.86.

Phreesia (NYSE:PHR) last released its earnings results on Wednesday, September 4th. The company reported ($0.31) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.37) by $0.06. The firm had revenue of $102.12 million during the quarter, compared to analyst estimates of $101.76 million. Phreesia had a negative net margin of 25.73% and a negative return on equity of 39.34%. As a group, analysts forecast that Phreesia, Inc. will post -1.23 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have commented on PHR shares. JMP Securities restated a “market outperform” rating and issued a $30.00 target price on shares of Phreesia in a research note on Thursday, September 5th. Truist Financial boosted their target price on Phreesia from $29.00 to $31.00 and gave the stock a “buy” rating in a report on Friday, September 6th. JPMorgan Chase & Co. boosted their target price on Phreesia from $27.00 to $28.00 and gave the stock an “overweight” rating in a report on Monday, September 9th. Needham & Company LLC reaffirmed a “buy” rating and issued a $29.00 price target on shares of Phreesia in a report on Thursday, September 5th. Finally, DA Davidson reiterated a “buy” rating and set a $32.00 price objective on shares of Phreesia in a research report on Thursday, September 5th. One investment analyst has rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $29.42.

Insider Activity

In other news, CEO Chaim Indig sold 5,295 shares of the company’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $23.25, for a total transaction of $123,108.75. Following the completion of the transaction, the chief executive officer now owns 1,223,736 shares of the company’s stock, valued at approximately $28,451,862. This represents a 0.43 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Yvonne Hui sold 2,791 shares of the company’s stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $20.92, for a total transaction of $58,387.72. Following the completion of the sale, the insider now directly owns 27,228 shares in the company, valued at approximately $569,609.76. The trade was a 9.30 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 29,997 shares of company stock valued at $667,943. Insiders own 5.80% of the company’s stock.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.